Status:
COMPLETED
MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-69 years
Phase:
PHASE2
Brief Summary
A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
Eligibility Criteria
Inclusion
- Patients have type 2 diabetes mellitus
- On diet/exercise therapy
Exclusion
- Patients have type 1 diabetes mellitus
Key Trial Info
Start Date :
June 1 2004
Trial Type :
INTERVENTIONAL
End Date :
April 25 2005
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00371007
Start Date
June 1 2004
End Date
April 25 2005
Last Update
April 4 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.